0 NASDAQ Companies - November 26, 2018Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 StudyTopline results for Phase III MicroStat program expected H1 2019 NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) — Eyenovia, Inc. […]Read More
0 TSX Venture News - November 26, 2018K92 Mining Inc. (“K92”) Releases Third Quarter Financial Results and Confirms 2018 Production GuidanceProduction of 9,549 gold ozs or 9,910 gold equivalent (AuEq) ozs for the Quarter at a cost of $742/gold oz […]Read More
0 TSX Venture News - November 26, 2018Tetra Bio-Pharma’s Dr. Chamberland Goes to Washington!ORLEANS, Ontario, Nov. 26, 2018 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX […]Read More
0 NYSE Companies - November 26, 2018Teladoc Health Launches Solution to Address Rising Prescription Drug Costs in CanadaUsing advanced analytics, Best Doctors Specialty Pharmacy Services helps employers and insurers identify and help members who would benefit from […]Read More
0 Canadian Stock Exchange News - November 26, 2018Security Devices International to Present at the 11th Annual LD Micro Main Event on December 5, 2018WAKEFIELD, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) — Security Devices International Inc. (“SDI” or the “Company”) (CSE: SDZ) (OTCQB: SDEV), […]Read More
0 NASDAQ Companies - November 26, 2018Electra Meccanica to Attend Upcoming Investor ConferencesVANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“Electra Meccanica” or the “Company”), a […]Read More
0 NYSE Companies - November 26, 2018Mizuho Expands its Healthcare Team with the Hiring of Senior Biotechnology Research Analyst Mara GoldsteinNEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) — Mizuho Americas today announced Mara Goldstein will join its equity research department […]Read More
0 NYSE Companies - November 26, 2018GameStop Announces Cyber Monday DealsRetailer Extends Black Friday Offers through Cyber Monday, Plus a Whole Lot More GRAPEVINE, Texas, Nov. 26, 2018 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - November 26, 2018SELLAS Life Sciences Announces Completion of Enrollment in Phase 2 Randomized Controlled Clinical Study of Nelipepimut-S Plus Trastuzumab in High-risk, High-expression HER2 Breast Cancer PatientsData Expected in Fourth Quarter of 2019 Second Clinical Study of Nelipepimut-S Plus Trastuzumab After Recently Announced Positive Phase 2b […]Read More
0 NASDAQ Companies - November 26, 2018Heavy Reading: as Wireless Network Operators Set Sights on Looming 5G Service Launch, Long-Term Potential Still Yet to be DefinedNew White Paper and Webinar Explore Differing Business Expectations for Future 5G Services and Innovation WILMINGTON, Del., Nov. 26, 2018 […]Read More